25 participants
Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-12
- Start Date:
- 2024-11-15
- Completion:
- 2026-04-30
Conditions
- Neoadjuvant Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet